Search Results (1 to 10 of 2280 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 608 Journal of Medical Internet Research
- 413 JMIR Research Protocols
- 267 JMIR Formative Research
- 184 JMIR mHealth and uHealth
- 101 JMIR Public Health and Surveillance
- 98 JMIR Mental Health
- 86 Online Journal of Public Health Informatics
- 73 JMIR Medical Informatics
- 52 JMIR Cancer
- 52 JMIR Human Factors
- 41 JMIR Dermatology
- 36 JMIR Medical Education
- 35 JMIR Aging
- 33 JMIR Pediatrics and Parenting
- 27 Iproceedings
- 25 JMIR Cardio
- 22 JMIR Serious Games
- 18 Interactive Journal of Medical Research
- 17 JMIR Diabetes
- 17 JMIR Infodemiology
- 17 JMIR Rehabilitation and Assistive Technologies
- 12 JMIR Perioperative Medicine
- 10 JMIR AI
- 10 Journal of Participatory Medicine
- 9 JMIR Nursing
- 4 JMIR XR and Spatial Computing (JMXR)
- 4 JMIRx Med
- 3 JMIR Biomedical Engineering
- 2 JMIR Neurotechnology
- 2 Medicine 2.0
- 1 Asian/Pacific Island Nursing Journal
- 1 JMIR Bioinformatics and Biotechnology
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

In the conceptual example illustrated in Figure 1, there are 4 sleep logs spanning 2 calendar days: C (day 0; 10:00 AM-noon), D (day 0; 2:00-3:30 PM), B (day 0; 10:00-11:30 PM), and A (day 1; 1:30-6:30 AM). To accurately compute sleep metrics, it is imperative to identify and include all primary sleep logs that fall within the primary sleep period, while distinguishing them from nonprimary sleep logs.
J Med Internet Res 2025;27:e71718
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

It was administered in doses ranging between 0.01 and 0.1 g/kg, 3 times daily either orally or intravenously (equivalent to 2.4-24 g/d for an 80 kg patient). Among patients with schizophrenia and catatonia, approximately 30 participants, the study showed a reduction of catatonic symptoms ranging from 60% to 70%. Specifically, there were improvements in anxiety, agitation, and restlessness.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section